Caryn Peterson

Corporate Officer/Principal at GOSSAMER BIO, INC.

Net worth: 42 790 $ as of 30/06/2026

67 year

51 connections

Health Technology

Commercial Services

Health Services

Profile

Caryn L.
Peterson was the founder of DSC Associates LLC, founded in 2004, and served as Managing Partner from 2004 to 2018.
Ms. Peterson is currently Chief Executive Officer at Alevium Pharmaceuticals, Inc. since 2009, Director at Aspen Neuroscience, Inc. since 2021, and Chief Development Officer at Gossamer Bio, Inc. since 2018.
Former positions include Associate Director-Regulatory Affairs at Amylin Pharmaceuticals, Inc. from 1989 to 1997, Principal at Hybritech, Inc. from 1981 to 1989, Vice President-Regulatory Affairs at Syndax Pharmaceuticals, Inc. from 2008 to 2018, Vice President-Regulatory Affairs at OncoSec Medical, Inc., Vice President-Regulatory Affairs at Ascenta Therapeutics, Inc., and Vice President-Regulatory Affairs at FeRx, Inc. from 1997 to 2004.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
GOSSAMER BIO, INC. 0.05%	19/03/2026	2,59,333 ( 0.05% )	42 790 $	30/06/2026

Caryn Peterson active positions

Companies	Position	Start
GOSSAMER BIO, INC.	Corporate Officer/Principal	-
Alevium Pharmaceuticals, Inc.	Chief Executive Officer	01/06/2009
Aspen Neuroscience, Inc. Aspen Neuroscience, Inc. Medical/Nursing ServicesHealth Services Provides neurological treatment services	Director/Board Member	23/06/2021

All active positions of Caryn Peterson

Former positions of Caryn Peterson

Companies	Position	End
DSC Associates LLC	Founder	01/01/2018
SYNDAX PHARMACEUTICALS, INC.	General Counsel	01/01/2018
FeRx, Inc. FeRx, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and distributes magnetic technology for the treatment of cancer	General Counsel	01/01/2004
Amylin Pharmaceuticals, Inc. Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases	General Counsel	01/01/1997
Hybritech, Inc. Hybritech, Inc. Miscellaneous Commercial ServicesCommercial Services Provides prostate diagnostic testing services	Corporate Officer/Principal	01/01/1989

See the detail of Caryn Peterson's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Caryn Peterson's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
Amylin Pharmaceuticals, Inc. Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases	Health Technology
Hybritech, Inc. Hybritech, Inc. Miscellaneous Commercial ServicesCommercial Services Provides prostate diagnostic testing services	Commercial Services
Syndax Pharmaceuticals, Inc. Syndax Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company	Health Technology
OncoSec Medical, Inc. OncoSec Medical, Inc. BiotechnologyHealth Technology Engages in discovery and development of novel immunotherapeutic products for immuno-oncology treatment	Health Technology
Ascenta Therapeutics, Inc. Ascenta Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines for cancer	Health Technology
FeRx, Inc. FeRx, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and distributes magnetic technology for the treatment of cancer	Health Technology
Alevium Pharmaceuticals, Inc.
DSC Associates LLC
Gossamer Bio, Inc. Gossamer Bio, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing therapeutics for immunology, inflammation and oncology diseases	Health Technology
Aspen Neuroscience, Inc. Aspen Neuroscience, Inc. Medical/Nursing ServicesHealth Services Provides neurological treatment services	Health Services